As the mutations are not fixed in the infected human population, it has been hypothesized that ADAR1 may play an antiviral role, while RdRp-caused mutations in patients with continued/persistent infection or high viremia are the main source of new SARS-CoV-2 variants.24 This evidence concerns the gene ADAR and infection.